UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Myelofibrosis: Current unmet needs, emerging treatments, and future perspectives

Cancer, 2024-06, Vol.130 (12), p.2091-2097

2024

Volltextzugriff (PDF)

JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis

The New England journal of medicine, 2012-03, Vol.366 (9), p.787-798

2012

Volltextzugriff (PDF)

Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria

The New England journal of medicine, 2021-03, Vol.384 (11), p.1028-1037

2021

Volltextzugriff (PDF)

Early intervention in myelofibrosis and impact on outcomes: A pooled analysis of the COMFORT‐I and COMFORT‐II studies

Cancer, 2023-06, Vol.129 (11), p.1681-1690

2023

Volltextzugriff (PDF)

The renaissance of interferon therapy for the treatment of myeloid malignancies

Blood, 2011-05, Vol.117 (18), p.4706-4715

2011

Volltextzugriff (PDF)

Interferon Alfa Therapy in CALR-Mutated Essential Thrombocythemia

The New England journal of medicine, 2014-07, Vol.371 (2), p.188-189

2014

Volltextzugriff (PDF)

A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis

Haematologica (Roma), 2015-09, Vol.100 (9), p.1139-1145

2015

Volltextzugriff (PDF)

Treatment of Polycythemia Vera With Hydroxyurea and Pipobroman: Final Results of a Randomized Trial Initiated in 1980

Journal of clinical oncology, 2011-10, Vol.29 (29), p.3907-3913

2011

Volltextzugriff (PDF)

Randomized, Single-Blind, Multicenter Phase II Study of Two Doses of Imetelstat in Relapsed or Refractory Myelofibrosis

Journal of clinical oncology, 2021-09, Vol.39 (26), p.2881-2892

2021

Volltextzugriff (PDF)

Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet

Journal of clinical oncology, 2011-02, Vol.29 (6), p.761-770

2011

Volltextzugriff (PDF)

CCND2 mutations are infrequent events in BCR-ABL1 negative myeloproliferative neoplasm patients

Haematologica (Roma), 2021-03, Vol.106 (3), p.863-864

2021

Volltextzugriff (PDF)

Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis

Blood, 2012-12, Vol.120 (25), p.4921-4928

2012

Volltextzugriff (PDF)

Characteristics and outcomes of patients with essential thrombocythemia or polycythemia vera diagnosed before 20 years of age: a systematic review

Haematologica (Roma), 2019-08, Vol.104 (8), p.1580-1588

2019

Volltextzugriff (PDF)

Luspatercept for the treatment of anemia in myelodysplastic syndromes and primary myelofibrosis

Blood, 2019-02, Vol.133 (8), p.790-794

2019

Volltextzugriff (PDF)

Revised response criteria for polycythemia vera and essential thrombocythemia: an ELN and IWG-MRT consensus project

Blood, 2013-06, Vol.121 (23), p.4778-4781

2013

Volltextzugriff (PDF)

Retrospective analysis of pacritinib in patients with myelofibrosis and severe thrombocytopenia

Haematologica (Roma), 2022-07, Vol.107 (7), p.1599-1607

2022

Volltextzugriff (PDF)

Treatment of essential thrombocythemia in Europe: a prospective long-term observational study of 3649 high-risk patients in the Evaluation of Anagrelide Efficacy and Long-term Safety study

Haematologica (Roma), 2018-01, Vol.103 (1), p.51-60

2018

Volltextzugriff (PDF)

Clinical outcomes of patients with myelofibrosis after immediate transition to momelotinib from ruxolitinib

Haematologica (Roma), 2024-02, Vol.109 (2), p.676

2024

Volltextzugriff (PDF)

An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms

Haematologica (Roma), 2015-09, Vol.100 (9), p.1117-1130

2015

Volltextzugriff (PDF)

Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference

Blood, 2009-05, Vol.113 (20), p.4829-4833

2009

Volltextzugriff (PDF)

Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria

The New England journal of medicine, 2021-03, Vol.384 (11), p.1028-1037

2021

Volltextzugriff (PDF)

Long-term treatment with pacritinib on a compassionate use basis in patients with advanced myelofibrosis

Haematologica (Roma), 2023-07, Vol.108 (7), p.1960-1964

2023

Volltextzugriff (PDF)

1 – 25 von 342

Suche als RSS-Feed

Aktive Filter

KollektionSingle Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(340)
Mit Volltextzugriff
(303)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(73)
Science & Technology
(73)
Humans
(70)
Hematology
(52)
Female
(38)
Male
(37)
Middle Aged
(32)
Adult
(27)
Aged
(25)
Biological And Medical Sciences
(24)
Hematologic And Hematopoietic Diseases
(24)
Medical Sciences
(24)
Life Sciences
(20)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(19)
Aged, 80 And Over
(17)
Oncology
(16)
Janus Kinase 2 - Genetics
(14)
Mutation
(14)
Primary Myelofibrosis - Drug Therapy
(13)
Treatment Outcome
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Myelofibrosis: Current unmet needs, emerging treatments, and future perspectives

JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis

Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria

Early intervention in myelofibrosis and impact on outcomes: A pooled analysis of the COMFORT‐I and COMFORT‐II studies

The renaissance of interferon therapy for the treatment of myeloid malignancies

Interferon Alfa Therapy in CALR-Mutated Essential Thrombocythemia

A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis

Treatment of Polycythemia Vera With Hydroxyurea and Pipobroman: Final Results of a Randomized Trial Initiated in 1980

Randomized, Single-Blind, Multicenter Phase II Study of Two Doses of Imetelstat in Relapsed or Refractory Myelofibrosis

Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet

CCND2 mutations are infrequent events in BCR-ABL1 negative myeloproliferative neoplasm patients

Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis

Characteristics and outcomes of patients with essential thrombocythemia or polycythemia vera diagnosed before 20 years of age: a systematic review

Luspatercept for the treatment of anemia in myelodysplastic syndromes and primary myelofibrosis

Revised response criteria for polycythemia vera and essential thrombocythemia: an ELN and IWG-MRT consensus project

Retrospective analysis of pacritinib in patients with myelofibrosis and severe thrombocytopenia

Treatment of essential thrombocythemia in Europe: a prospective long-term observational study of 3649 high-risk patients in the Evaluation of Anagrelide Efficacy and Long-term Safety study

An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults

Clinical outcomes of patients with myelofibrosis after immediate transition to momelotinib from ruxolitinib

Treatment of progression of Philadelphia-negative myeloproliferative neoplasms to myelodysplastic syndrome or acute myeloid leukemia by azacitidine: a report on 54 cases on the behalf of the Groupe Francophone des Myelodysplasies (GFM)

An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms

Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference

Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria

Long-term treatment with pacritinib on a compassionate use basis in patients with advanced myelofibrosis

Role of red cell mass evaluation in myeloproliferative neoplasms with splanchnic vein thrombosis and normal hemoglobin value: a study of the France Intergroupe des Syndromes myeloprolifératifs

Aktive Filter

Suchergebnisse filtern